Aenova is the company formed by the merger of two separate investments made by Bridgepoint: Swiss Caps, Europe’s No 2 contract soft capsule manufacturer of vitamins, minerals, supplements and pharma products, and Dragenopharm, a German contract manufacturer for the generic prescription drugs market.
| www.aenova.de | ||||
| Sector | Healthcare | Location | Frankfurt | |
| Acquired | 2006 | Deal size | N/D | |
Formed in 2008, Aenova now has the largest contract tablet manufacturing capacity in Europe and is a leading producer of generic drugs. Combining both businesses also creates the opportunity to improve manufacturing efficiency, and through sharing technological know-how, accelerate both product development and expansion of its customer base.
